• SENSEX
    NIFTY 50
Business

India’s drug regulator grants Gilead Sciences marketing authorisation for remdesivir

Updated : June 02, 2020 01:50 PM IST

The approval process for remdesivir was accelerated in view of the emergency situation and the unmet need for medicines in light of the coronavirus outbreak.
India’s drug regulator grants Gilead Sciences marketing authorisation for remdesivir

You May Also Like

Live TV
Advertisement